Cibus Inc
CBUS1.420USD
+0.070+5.19%
Handelsschluss 09/19, 16:00（ET）Kurse um 15 Minuten verzögert
74.52MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Cibus Inc Unternehmen
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
Unternehmensinformationen
BörsenkürzelCBUS
Name des UnternehmensCibus Inc
IPO-datumJul 20, 2017
CEODr. Peter Ronald Beetham, Ph.D.
Anzahl der mitarbeiter157
WertpapierartOrdinary Share
GeschäftsjahresendeJul 20
Addresse6455 Nancy Ridge Drive
StadtSAN DIEGO
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl92121
Telefon18584500008
Websitehttps://www.cibus.com/
BörsenkürzelCBUS
IPO-datumJul 20, 2017
CEODr. Peter Ronald Beetham, Ph.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Ms. Kimberly Ann (Kim) Box
Ms. Kimberly Ann (Kim) Box
Director
Director
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
Mr. Jean-Pierre Lehmann
Mr. Jean-Pierre Lehmann
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Umsatzaufteilung
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
1.03M
0.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Tue, Aug 19
Aktualisiert: Tue, Aug 19
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Riggs (Rory B)
27.84%
Fidelity Management & Research Company LLC
13.64%
JPL Investments SA
3.19%
Vantage Consulting Group, Inc.
2.18%
Gratia Capital, LLC
1.63%
Andere
51.52%
Aktionäre
Aktionäre
Anteil
Riggs (Rory B)
27.84%
Fidelity Management & Research Company LLC
13.64%
JPL Investments SA
3.19%
Vantage Consulting Group, Inc.
2.18%
Gratia Capital, LLC
1.63%
Andere
51.52%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
30.25%
Investment Advisor
17.55%
Investment Advisor/Hedge Fund
3.28%
Corporation
3.26%
Hedge Fund
2.52%
Research Firm
0.56%
Family Office
0.21%
Bank and Trust
0.06%
Andere
42.31%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
166
29.20M
60.37%
+13.40M
2025Q1
171
17.83M
39.89%
+256.22K
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Riggs (Rory B)
14.63M
30.24%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
4.60M
9.5%
+647.11K
+16.38%
Mar 31, 2025
JPL Investments SA
1.67M
3.46%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
2.36%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
892.12K
1.84%
+41.63K
+4.90%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.03M
2.13%
-16.63K
-1.59%
Mar 31, 2025
Beetham (Peter Ronald)
382.44K
0.79%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.77%
+60.00K
+19.06%
Mar 24, 2025
Geode Capital Management, L.L.C.
473.61K
0.98%
+81.22K
+20.70%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Sep 2
Aktualisiert: Tue, Sep 2
Name
Anteil
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Anteil0.01%
iShares Russell 2000 Value ETF
Anteil0%
Global X Russell 2000 ETF
Anteil0%
Proshares Ultra Russell 2000
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
ProShares Hedge Replication ETF
Anteil0%
iShares Core S&P Total U.S. Stock Market ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
